BRCA1-IN-2
CAS No. 1622262-55-8
BRCA1-IN-2( —— )
Catalog No. M32817 CAS No. 1622262-55-8
BRCA1-IN-2 is a cell membrane-crossing BRCA1 protein-protein interaction (PPI) inhibitor with antitumor activity that acts by disrupting the interaction of BRCA1 (BRCT)2 with proteins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 454 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBRCA1-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionBRCA1-IN-2 is a cell membrane-crossing BRCA1 protein-protein interaction (PPI) inhibitor with antitumor activity that acts by disrupting the interaction of BRCA1 (BRCT)2 with proteins.
-
DescriptionBRCA1-IN-2 (compound 15) is a cell-permeable protein-protein interaction (PPI) inhibitor for BRCA1 with an IC50 of 0.31 μM and a Kd of 0.3 μM, which shows antitumor activities via the disruption of BRCA1 (BRCT)2/protein interactions.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1622262-55-8
-
Formula Weight544.54
-
Molecular FormulaC26H33N4O7P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (183.64 mM; Ultrasonic )
-
SMILESC(CC(N[C@H](C(NCC(NCCCCC1=CC=CC=C1)=O)=O)COP(=O)(O)O)=O)C=2C=3C(NC2)=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Na Z, et al. Protein-Protein Interaction Inhibitors of BRCA1 Discovered Using Small Molecule Microarrays. Methods Mol Biol. 2017;1518:139-156.?
molnova catalog
related products
-
Ac-tBu-Gly-tBu-Gly-A...
Ac-tBu-Gly-tBu-Gly-Asn(Me)2-Ala-AMC
-
Agmatine sulfate sal...
Agmatine sulfate is a bioactive metabolite of the arginine amino acid. It exerts modulatory action at multiple molecular targets such as neurotransmitter systems ion channels and nitric oxide synthesis. It is an endogenous agonist at imidazoline receptor and a NO synthase inhibitor.
-
TBMP
TBMP is the viral envelope protein hemagglutinin (HA)-mediated entry novel inhibitor.
Cart
sales@molnova.com